Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hebert

Showing results (321-330 of 460) with videos related to

Pageof 46
Sort By:
JAMA Dermatology|May 26, 2018
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical TrialMary Kay Koenig, Cynthia S Bell, Adelaide A Hebert, et al.
Journal of Drugs in Dermatology : JDD|September 5, 2025
The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment OptionLawrence A Schachner, Adelaide A Hebert, Nanette Silverberg, et al.
Kidney International|September 17, 2005
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosusBrad H Rovin, Huijuan Song, Lee A Hebert, et al.
The Journal of Clinical Investigation|January 1, 1986
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruliF J Waxman, L A Hebert, F G Cosio, et al.
Current Directions in Autoimmunity|January 15, 2004
The intricate role of complement component C4 in human systemic lupus erythematosusYan Yang, Erwin K Chung, Bi Zhou, et al.
Clinical and Experimental Immunology|January 18, 2006
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flareD J Birmingham, K F Gavit, S M McCarty, et al.
American Journal of Clinical Dermatology|March 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic DermatitisAmy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, et al.
The British Journal of Dermatology|June 19, 2007
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trialJ M Spergel, M Boguniewicz, A S Paller, et al.
Kidney International|July 27, 2007
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flaresD J Birmingham, B H Rovin, G Shidham, et al.
Maternal & Child Nutrition|March 22, 2024
Before and after study of a national complementary and supplementary feeding programme in Rwanda, 2017-2021Katharine A Hebert, Emmanuel Nsengiyumva, Christine Kayitesi, et al.
Pageof 46

Showing results (321-330 of 460) with videos related to

Sort By:
Pageof 46
JAMA Dermatology|May 26, 2018
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical TrialMary Kay Koenig, Cynthia S Bell, Adelaide A Hebert, et al.
Journal of Drugs in Dermatology : JDD|September 5, 2025
The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment OptionLawrence A Schachner, Adelaide A Hebert, Nanette Silverberg, et al.
Kidney International|September 17, 2005
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosusBrad H Rovin, Huijuan Song, Lee A Hebert, et al.
The Journal of Clinical Investigation|January 1, 1986
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruliF J Waxman, L A Hebert, F G Cosio, et al.
Current Directions in Autoimmunity|January 15, 2004
The intricate role of complement component C4 in human systemic lupus erythematosusYan Yang, Erwin K Chung, Bi Zhou, et al.
Clinical and Experimental Immunology|January 18, 2006
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flareD J Birmingham, K F Gavit, S M McCarty, et al.
American Journal of Clinical Dermatology|March 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic DermatitisAmy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, et al.
The British Journal of Dermatology|June 19, 2007
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trialJ M Spergel, M Boguniewicz, A S Paller, et al.
Kidney International|July 27, 2007
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flaresD J Birmingham, B H Rovin, G Shidham, et al.
Maternal & Child Nutrition|March 22, 2024
Before and after study of a national complementary and supplementary feeding programme in Rwanda, 2017-2021Katharine A Hebert, Emmanuel Nsengiyumva, Christine Kayitesi, et al.
Pageof 46